Arintra vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $21M Series A (Aug 2025) led by Peak XV Partners with Endeavor Health Ventures and YC. Coding Copilot enables 90% faster chart coding. 5%+ revenue uplift, 43%+ fewer denials.
About
Arintra is an AI medical coding platform that autonomously codes clinical charts with no human intervention, delivering measurable improvements in coding accuracy and speed. The company raised $21 million in Series A financing in August 2025 led by Peak XV Partners (formerly Sequoia India/SEA), with Endeavor Health Ventures and Y Combinator as co-investors. The Coding Copilot enables medical coders to work 90% faster by surfacing recommended codes with supporting clinical documentation.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.